Artificial intelligence is driving breakthroughs across biotech, from AI-enhanced ultrasound diagnostics to innovative tools for clinical research acceleration. Ultromics reported superior FDA-cleared AI analysis for early cardiac amyloidosis detection, improving diagnostic accuracy. Meanwhile, deep geometric learning models like InfEHR bolster clinical phenotyping from electronic health records, offering precision medicine applications. Other AI developments include language models to streamline injury risk prediction and generative AI systems focused on environmental sustainability to reduce carbon footprints in biotech workflows.